相关实验视频

Updated: Jan 11, 2026

Invasive Hemodynamic Monitoring of Aortic and Pulmonary Artery Hemodynamics in a Large Animal Model of ARDS

Invasive Hemodynamic Monitoring of Aortic and Pulmonary Artery Hemodynamics in a Large Animal Model of ARDS

Published on: November 26, 2018

右心室衰竭的高级血液动力学:评估使用心肌性能得分的使用

Jiho Han¹, Mikail Siddiki², Sara Kalantari²

¹Division of Cardiology, Columbia University Irving Medical Center, New York, New York.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

|November 15, 2025

概括

新型右心室肌动脉性能评分 (RV-MPS) 在模拟中可靠地估计了右心室功能. 这一分数预测了晚期心力衰竭患者的结果,包括死亡或需要心脏替代疗法.

科学领域:

心脏病学心脏病学
医疗模拟医疗模拟
血液动力学血液动力学

背景情况:

晚期心力衰竭显著影响右心室 (RV) 功能.
准确评估RV功能对于预后和管理至关重要.
需要新的血液动力学参数来更好地评估RV性能.

研究的目的:

评估右心室肌动脉性能得分 (RV-MPS) 作为RV功能的新标志物.
评估晚期心力衰竭患者RV-MPS的预后价值.

主要方法:

执行了800个压力-体积循环的in silico模拟,以计算RV-MPS.
使用肺动脉脉动率指数 (PAPI) 和右心室心脏输出功率 (RV-CPO) 计算RV-MPS.
在使用侵入性血液动力学数据的223名晚期心力衰竭患者中验证了RV-MPS.

主要成果:

在模拟中,RV-MPS与RV EES以及机械效率相关.
RV-MPS独立预测了死亡或心脏替代疗法的1年复合结果 (OR:0.64,P=0.037).
在LVAD植入之前,较低的RV-MPS (<0.5) 与增加的RV失败发生率相关 (66.7%对16.7%,P=0.003).

结论:

RV-MPS是RV功能在中的可靠估计器.
RV-MPS作为高级心力衰竭中不良结果的独立预测器.
在晚期心力衰竭患者中,RV-MPS显示出预后的潜力.

关键词:

先进的血液动力学.心脏的能量学心脏输出功率输出的心脏功率.心肌功能表现得分 (Myocardial Performance Score) 是指心肌功能表现得分是指心肌功能表现得分肺动脉脉动力指数是指肺动脉脉动力指数.右心室衰竭是什么意思

更多相关视频

Comprehensive Echocardiographic Assessment of Right Ventricle Function in a Rat Model of Pulmonary Arterial Hypertension

Comprehensive Echocardiographic Assessment of Right Ventricle Function in a Rat Model of Pulmonary Arterial Hypertension

Published on: January 20, 2023

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

相关概念视频

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...

Cardiomyopathy II: Dilated Cardiomyopathy

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...